Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07270276 · ClinicalTrials.gov registry record · NA
The Impact of Dry Needling on Electrophysiological and Ultrasound-based Biomarkers for Myofascial Pain
A NA study of Trigger Point in Trapezius Muscle, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 2
- Study locations
NCT07270276 is a NA study of Trigger Point in Trapezius Muscle that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 70 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT07270276, a NA study of Trigger Point in Trapezius Muscle, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this interventional study is to determine how well dry-needling can treat pain in people with Myofascial Pain Syndrome. The main questions it aims to answer are: * Does dry needling improve pain for people with a trigger point (a tender, tight spot in the muscle)? * How well can Electrical Impedence Myography (EIM), Myofiber Threshold Tracking (TT), and Ultrasound (US) detect changes in the muscle related to dry needling treatment? Researchers will compare dry needling to a placebo (a treatment that does not enter the trigger point) to see if dry needling works to treat Myofascial Pain Syndrome with trigger points in the trapezius muscle (the muscle that extends over the back of the neck and shoulders), as measured by these three outcome measures (EIM, US, TT). Participants will: * Visit the clinic twice: once to receive dry needling treatment, and once for a follow-up * Have muscle measurements taken before treatment and at follow-up * Have a daily survey to record the intensity of their pain
Conditions Studied
Interventions
- PROCEDURE Dry Needling
- PROCEDURE Sham Treatment
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07270276
The ClinicalTrials.gov registry entry for NCT07270276 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Trigger Point in Trapezius Muscle appearing as the primary indexed condition, and to 2 interventions - of which Dry Needling is the first listed.
NCT07270276 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07270276 about?
NCT07270276 is a clinical study titled "The Impact of Dry Needling on Electrophysiological and Ultrasound-based Biomarkers for Myofascial Pain". The goal of this interventional study is to determine how well dry-needling can treat pain in people with Myofascial Pain Syndrome. The main questions it aims to answer are: * Does dry needling improve pain for people with a trigger point (a tender, tight spot in the muscle)? * How well can Electri...
What is the current status of trial NCT07270276?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-02-01. Estimated completion is 2028-08-31.
What conditions does trial NCT07270276 study?
This clinical trial studies the following conditions: Trigger Point in Trapezius Muscle.
What interventions are being tested in trial NCT07270276?
The interventions under investigation include: Dry Needling (PROCEDURE), Sham Treatment (PROCEDURE).
Who is sponsoring clinical trial NCT07270276?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07270276 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.